Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway

Cancer Research - United States
doi 10.1158/0008-5472.can-12-1248
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer

Cancer Research
Cancer ResearchOncology
2011English

Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

The Hedgehog Signaling Pathway: A Promising Target for Therapeutic Development

Cancer therapy & Oncology International Journal
2018English

Hedgehog Acyltransferase as a Target in Estrogen Receptor Positive, HER2 Amplified, and Tamoxifen Resistant Breast Cancer Cells

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

FOXP1 Regulation via the PI3K/Akt/p70S6K Signaling Pathway in Breast Cancer Cells

Oncology Letters
Cancer ResearchOncology
2015English

Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer

Journal of the American College of Surgeons
Surgery
2010English

Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2017English

BMP9 Inhibits the Growth of Breast Cancer Cells by Downregulation of the PI3K/Akt Signaling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy